Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Novo Nordisk, Inc. Patent Department patentsThe following is a sampling of recent Novo Nordisk, Inc. Patent Department patent applications (USPTO Patent Application #, Patent Title) sorted by month.
May 2008 - Novo Nordisk, Inc. Patent Department patents
20080119454 - Aryl carbonyl derivatives as therapeutic agents
20080119455 - Aryl carbonyl derivatives as therapeutic agents
20080113944 - Novel indole derivatives
20080113968 - Substituted piperazines and diazepanes
20080113995 - Substituted homopiperidine, piperidine or pyrrolidine derivatives
20080114036 - Novel compounds, their preparations and use
20080114299 - Remote commander to be used with a drug delivery device
20080108557 - Modified proteins
20080108598 - Pharmaceutical use of substituted amides
20080099470 - Method of fixing a needle cannula in a radiation transmissive body
20080102064 - Pharmaceutical composition comprising factor vii polypeptides and protein c inhibitors
20080103097 - Glp-1 derivatives ii
April 2008 - Novo Nordisk, Inc. Patent Department patents
20080097322 - Syringe device
March 2008 - Novo Nordisk, Inc. Patent Department patents
20080075709 - Pharmaceutical composition comprising factor vii polypeptides and thrombomodulin polypeptides
20080075711 - Combined use of factor vii polypeptides and factor ix polypeptides
20080076700 - Method for the preparation of oxime, thiazolidine, dithiane, dithiolane, or hydrazone linked analogues of growth hormone
20080076702 - Combined use of factor vii polypeptides and factor viii polypeptides
20080076705 - Insulin derivatives
20080069810 - Pharmaceutical composition comprising factor vii polypeptides and tafi polypeptides
20080060644 - Method of treating diabetes mellitus in a patient
20080064068 - Method of production of recombinant proteins in eukaryote cells
20080064630 - Osteogenic growth peptide fusion proteins
20080065026 - Injection device
20080057059 - Pharmaceutical composition comprising factor vii polypeptides and protein s inhibitors
20080058255 - Glycosylation-disrupted factor vii variants
20080058266 - Pharmaceutical compositions comprising factor vii polypeptides and factor xi polypeptides
February 2008 - Novo Nordisk, Inc. Patent Department patents
20080045450 - Glp-2 derivatives
20080039373 - Pegylated factor vii glycoforms
20080039387 - Novel peptides for use in the treatment of obesity
20080033147 - Method for producing acylated peptides
January 2008 - Novo Nordisk, Inc. Patent Department patents
20080026987 - Use of liver-selective glucokinase activators
20080027138 - Novel niddm regimen
20080020183 - Markings on transparent plastic
20080015519 - Needle mounting system and a method for mounting a needle assembly
20080009805 - Integrated package
20080010693 - Human coagulation factor vii polypeptides
December 2007 - Novo Nordisk, Inc. Patent Department patents
20070292520 - Pulmonary insulin crystals
20070293742 - Medical system and a method of controlling the system for use by a patient for medical self treatment
20070287669 - Combined use of derivatives of glp-1 analogs and ppar ligands
20070280920 - Pharmaceutical composition comprising a factor viia and a factor xiii
November 2007 - Novo Nordisk, Inc. Patent Department patents
20070270408 - Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines
20070265189 - Insulin and igf-1 receptor agonists and antagonists
October 2007 - Novo Nordisk, Inc. Patent Department patents
20070243183 - Use of factor viia or factor viia equivalents for preventing or attenuating haemorrhage growth, and/or oedema generation following intracerebral haemorrhage
20070244054 - Peptides for use in treating obesity
20070244445 - Injection device
20070239133 - Needle insertion sensor
20070232542 - Methods for modifying cell motility using factor viia antagonist
20070233008 - Cartridge and medical delivery system accommodating such cartridge
September 2007 - Novo Nordisk, Inc. Patent Department patents
20070225212 - Use of a peptide
20070219135 - Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptide
20070213265 - Kunitz-type sequences and polypeptides
20070207956 - Stabilised solid compositions of factor vii polypeptides
20070207964 - Combined use of a glp-1 compound and another drug for treating dyslipidemia
20070208163 - Method for treatment of protein precipitates
August 2007 - Novo Nordisk, Inc. Patent Department patents
20070203058 - Novel glp-1 derivatives
20070203068 - Stimulation of beta cell proliferation
20070197552 - Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states
20070190159 - Polyamino acid-based insulin preparation
20070184847 - Method and a system for safe pairing of wireless communication devices
20070185128 - Compounds and compositions for treating obesity
20070186130 - Reduced size transmission data packet header format for a medical device
20070179096 - pharmaceutical formulation
20070179352 - Device for displaying data relevant for a diabetic patient
July 2007 - Novo Nordisk, Inc. Patent Department patents
20070167373 - Combined use of a glp-1 compound and a modulator of diabetic late complications
20070161568 - Use of glp-1 peptides
20070155654 - Novel formulations
June 2007 - Novo Nordisk, Inc. Patent Department patents
20070141662 - Fusion proteins and methods of cleavage of such proteins
20070142625 - Virus filtration of liquid factor vii compositions
20070129284 - Single-chain insulin
May 2007 - Novo Nordisk, Inc. Patent Department patents
20070122384 - Method for treating inflammatory bowel disease
20070122884 - Factor vii glycoforms
20070113861 - Cap for a medical device
20070111926 - Conjugation of peptides
20070112301 - Actuator system comprising detector means
20070104596 - Actuator system comprising lever mechanism
20070105750 - Novel plasma protein affinity tags
20070105770 - Transglutaminase mediated conjugation of peptides
April 2007 - Novo Nordisk, Inc. Patent Department patents
20070093411 - Zinc-free and low-zinc insulin preparations having improved stability
20070093417 - Novel glp-1 analogues linked to albumin-like agents
20070082844 - Regulation of food preference using glp-1 agonists
20070078086 - Uses of factor viia or factor viia equivalents for treating late complications of trauma
20070078087 - Use of factor viia or factor viia equivalents for treating trauma
20070078415 - Non grinded needle tip-geometry for an injection needle
March 2007 - Novo Nordisk, Inc. Patent Department patents
20070049523 - Liquid composition of modified factor vii polypeptides
20070049531 - Glp-1 agonist and cardiovascular complations
20070049864 - Impulse chamber for jet delivery device
20070049865 - Retraction means for transcutaneous device
20070049873 - Impulse chamber for jet delivery device
February 2007 - Novo Nordisk, Inc. Patent Department patents
20070042956 - Novel glp-1 compounds
20070037746 - Novel compounds
20070037966 - Hydrophobic interaction chromatography purification of factor vii polypeptides
20070030764 - Device with time indicating means
20070031374 - Combination therapy
20070027077 - Pharmaceutical compositions comprising factor vii polypeptides and factor xi polypeptides
20070027091 - Novel melanocortin receptor agonists
20070027140 - N-heteroaryl indole carboxamides and analogues thereof, for use as glcokinase activators in the treatment of diabetes
January 2007 - Novo Nordisk, Inc. Patent Department patents
20070021338 - Stabilised compositions of factor vii
20070021340 - Use of blood coagulation factor xiii for treating hemophilia a
20070021716 - Nozzle device with skin stretching means
20070021733 - Internal fluid connector
20070014788 - Laminin-5 modulators and uses thereof
20070014951 - Transparent, flexible, impermeable plastic container for storage of pharmaceutical liquids
20070015709 - Method for treating hemophilia b
20070015757 - Novel glucagon antagonists/inverse agonists
20070016143 - Medical delivery device having air shot means
20070016159 - Reservoir device with inclined needle
20070010424 - Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
20070010559 - Indole derivatives for use as chemical uncoupler
20070004634 - Insulin and igf-1 receptor agonists and antagonists
20070004794 - Novel salicylic anilides
20070004799 - Novel compounds for the treatment of obesity
December 2006 - Novo Nordisk, Inc. Patent Department patents
20060293221 - Mucosal repair by tff2 peptides
20060293241 - Pharmaceutical composition comprising a factor vii polypeptide and epsilon-aminocaproic acid
20060286629 - Processing of peptides and proteins
20060287221 - Soluble pharmaceutical compositions for parenteral administration comprising a glp-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia
20060287393 - Novel compounds, their preparation and use
20060287432 - Peptide purification by means of metal ion affinity chromatography
20060287629 - Jet injector with a bi-stable spring
20060280740 - Compositions and methods for regulating nk cell activity
20060281721 - Hrt formulations
20060281980 - Apparatus and method for determining a physiological condition
20060276398 - Combined use of factor vii polypeptides and factor viii polypeptides
November 2006 - Novo Nordisk, Inc. Patent Department patents
20060264606 - Processes for making acylated insulin
20060264835 - Medical skin mountable device
20060257472 - Stability of progestogen formulations
20060257479 - Long-acting molecules in sustained release formulations
20060258561 - Novel nph insulin preparations
20060258851 - Hybird molecules having factor vii/viia activity
20060252129 - Human coagulation factor vii variants
20060253296 - Medical advisory system
20060243804 - Container comprising code information elements
20060247167 - Stable formulations of peptides
20060247171 - Use of a peptide
20060247174 - Use of a peptide
20060247581 - Threaded rod and nut assembly
20060247583 - Tapered pen syringe needle
October 2006 - Novo Nordisk, Inc. Patent Department patents
20060228331 - Il-21 derivatives and variants
20060229248 - Use of glp-1 compound for treatment of critically ill patients
September 2006 - Novo Nordisk, Inc. Patent Department patents
20060211605 - Mucosal repair by tff dimer peptides
20060211616 - Purification of glucagon-like peptides
20060211621 - Combined use of factor vii polypeptides and factor ix polypeptides
20060205036 - Coagulation factor vii polypeptides
20060205648 - Liquid, aqueous pharmaceutical compositions of factor vii polypeptides
20060198819 - Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
20060199766 - Pharmaceutical composition comprising a factor viia and a factor xiii
20060200073 - Portable drug delivery device having an encapsulated needle
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Novo Nordisk, Inc. Patent Department in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Novo Nordisk, Inc. Patent Department with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|
REGISTER now for FREE 
